Endra Life Sciences Inc Reports Results For The Quarter Ended In December: Earnings Summary

ENDRA Life Sciences

28/03/2024 21:02

* ENDRA Life Sciences Inc  NDRA.OQ  reported a quarterly
adjusted
loss of 5 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -96 cents.  The lone analyst forecast for the
quarter was for a loss of 36 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * ENDRA Life Sciences Inc's reported EPS for the quarter was
a
loss of 5 cents​.
    * The company reported a quarterly loss of $1.46 million.
    * ENDRA Life Sciences Inc shares had fallen by 61.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $11.00 

This summary was machine generated from LSEG data March 28 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.36          -0.05          Beat
 Sep. 30 2023      -0.43          -0.40          Beat
 Jun. 30 2023      -0.55          -0.43          Beat
 Mar. 31 2023      -1.04          -0.93          Beat